Precise clinical trial results translation for global submissions

Clinical trial results contain dense scientific language, complex statistical analyses, and safety-critical information. Generic translation approaches are not enough. Regulators, investigators, and payers must interpret your data in their native language with zero ambiguity. Our clinical trial results translation service focuses on precision, consistency, and traceability from protocol-defined endpoints to final conclusions.

Kings of Translation works with experienced medical translators who have backgrounds in life sciences, pharmacology, and clinical research. They understand concepts such as primary and secondary endpoints, inclusion and exclusion criteria, safety profiles, PK/PD analysis, and patient-reported outcomes. This ensures your translated results accurately convey clinical significance, not just literal wording.

We commonly translate clinical study reports (CSRs), summary of clinical efficacy (SCE), summary of clinical safety (SCS), tables, listings and figures (TLFs), investigator brochures (IBs), and layperson summaries of results. Our workflows are designed to support multi-country trials, bridging studies, and submissions to authorities such as FDA, EMA, and other global regulatory bodies.

To support end-to-end documentation, many sponsors combine results translation with our broader medical translation services so protocols, informed consent forms, and patient-facing materials are fully aligned. This integrated approach helps minimize discrepancies across languages and supports smoother audits and inspections.

Every project follows a rigorous QA process with bilingual review, terminology checks, and formatting verification. For high-visibility submissions or parallel global filings, we can implement harmonized glossaries and style guides to keep your clinical terminology consistent across all target markets.

When submitting clinical trial results to authorities, clarity and consistency are as important as accuracy. Our team is familiar with common regulatory expectations and document structures for FDA, EMA, and other international agencies. We tailor translations to mirror original layouts, table numbering, figure captions, and cross-references so reviewers can easily verify your data.

Whether you are preparing a full dossier, responding to agency queries, or aligning documentation across regions, we can handle large volumes of TLFs, narratives, and summary sections within tight timelines. For U.S.-focused sponsors, translated results can support FDA submissions while also being reused for EMA, PMDA, and additional global authorities to streamline your globalization strategy.

Data confidentiality is essential. Kings of Translation operates with strict NDAs, secure file transfer, and controlled project access. Only vetted medical linguists and in-house project managers handle your clinical data. We can also assign closed teams for long-term studies to maintain continuity and deep familiarity with your program.

Our pricing is transparent: standard medical translation starts at $0.06 per word, while certified or notarized documentation, when required for certain regulatory or ethics committee processes, begins at $32.90 per page. You receive detailed quotes in advance, so budgeting for multi-country trials and extensions is straightforward.

If you also require translations for related materials such as patient diaries, questionnaires, or post-authorization safety reports, our broader certified translation services can be integrated into a single, coordinated workflow managed by a dedicated project team.

Every clinical trial results translation project begins with a clear understanding of your objectives: target authorities, languages required, timelines, and document scope. We assign a dedicated project manager who coordinates linguists, medical editors, and quality assurance specialists to keep the process predictable and efficient.

First, we analyze your files—CSRs, TLFs, narratives, and summaries—to identify terminology density, repeated segments, and formatting complexity. We then build or adapt a terminology glossary based on your protocol, investigator brochure, and previous documentation. This glossary is shared with all linguists to guarantee consistent use of drug names, indications, endpoints, and safety terms.

Next, translation is performed by native-speaking medical experts in the target language. Every translation undergoes a second-step bilingual review and specialist editing, focusing on numeric consistency, table headings, footnotes, and cross-referenced sections. For projects that require an extra level of assurance, we can add a third, independent QA pass involving automated checks and manual validation.

Formatting and layout are then aligned with your source documents. This includes correct rendering of tables, charts, statistical notation, and units. Our team can work with Word, Excel, PDF, and common statistical exports, helping ensure that translated TLFs remain easy to interpret by clinical and statistical reviewers.

Finally, we deliver your clinical trial results translations in submission-ready formats. If needed, we can provide certificates of accuracy or work alongside your internal quality and regulatory teams during audits, inspections, or external reviews. Our goal is to act as a long-term partner supporting your global clinical development pipeline.